Abstract
Introduction Anaplastic multiple myeloma (AMM) is a very rare and aggressive morphologic variant of multiple myeloma with a historically poor prognosis. The term “anaplastic myeloma” is used to describe a plasma cell malignancy involving immature plasma cells of pleomorphic morphology with high-grade transformation and extramedullary involvement with large, poorly differentiated cells. Anaplastic morphology can be present at the initial diagnosis or can appear later in the disease course. Historically, this disease has been very resistant to chemotherapy. We have described 2 cases of anaplastic myeloma and the poor response to novel myeloma therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
